Myotonic Dystrophy Type 2
What's New
Last Posted: Sep 12, 2024
- Intellectual Profile in Myotonic Dystrophy Type 1 and Its Association With Its Onset: A Systematic Review and Meta-Analysis.
Carlos Pascual-Morena, et al. Pediatric neurology 2024 0 9-17 - Co-occurrence of CAPN3 homozygous mutation and CCTG expansion in the CNBP gene in a patient with muscular dystrophy.
Wiktoria Radziwonik-Fr?czyk, et al. Postepy psychiatrii neurologii 2024 0 (2) 109-114 - Next generation sequencing panel as an effective approach to genetic testing in patients with a highly variable phenotype of neuromuscular disorders.
Wiktoria Radziwonik-Fraczyk, et al. Neurogenetics 2024 0 - Diagnosis and Management of Myotonic Dystrophy Type 1
J Hartman et al, JAMA March 11, 2024 - Myotonic dystrophy type 1: 13 years of experience at a tertiary hospital. Clinical and epidemiological study and genotype-phenotype correlation.
J P Sánchez Marín, et al. Neurologia 2023 0 - Origin of the myotonic dystrophy type 1 mutation in Mexican population and influence of Amerindian ancestry on CTG repeat allelic distribution.
Murillo-Melo N M, et al. Neuromuscular disorders : NMD 2017 0 (12) 1106-1114 - Analysis of mutational dynamics at the DMPK (CTG)n locus identifies saliva as a suitable DNA sample source for genetic analysis in myotonic dystrophy type 1.
Corrales Eyleen, et al. PloS one 2019 0 (5) e0216407 - MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1.
Flower Michael, et al. Brain : a journal of neurology 2019 0 (7) 1876-86 - Longitudinal increases in somatic mosaicism of the expanded CTG repeat in myotonic dystrophy type 1 are associated with variation in age-at-onset.
Morales Fernando, et al. Human molecular genetics 2020 0 (15) 2496-2507 - Parental repeat length instability in myotonic dystrophy type 1 pre- and protomutations.
Joosten Isis B T, et al. European journal of human genetics : EJHG 2020 0 (7) 956-962 - Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration.
Jimenez-Marin Antonio, et al. Neuropathology and applied neurobiology 2021 0 (7) 1092-1108 - Disease impact in chronic progressive external ophthalmoplegia: more than meets the eye.
Smits Bart W, et al. Neuromuscular disorders : NMD 2011 0 (4) 272-8 - Dutch myotonic dystrophy type 2 patients and a North-African DM2 family carry the common European founder haplotype.
Coenen Marieke J H, et al. European journal of human genetics : EJHG 2011 0 (5) 567-70 - Proximal myotonic myopathy: a syndrome with a favourable prognosis?
Meola Giovanni, et al. Journal of the neurological sciences 2002 0 (2) 89-96 - Characterization of full-length CNBP expanded alleles in myotonic dystrophy type 2 patients by Cas9-mediated enrichment and nanopore sequencing.
Alfano Massimiliano et al. eLife 2022 11 - Ancestral Origin of the First Indian Families with Myotonic Dystrophy Type 2.
Damen M J, et al. Journal of neuromuscular diseases 2021 5 - Genotype-phenotype correlations in pediatric patients with myotonic dystrophy type 1.
Kim Hyeong Jung, et al. Korean journal of pediatrics 2018 9 - Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1.
Winkler Nelson S, et al. Investigative ophthalmology & visual science 2018 6 (7) 3053-3057 - Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy.
Mootha V Vinod, et al. Investigative ophthalmology & visual science 2017 9 (11) 4579-4585 - A polymorphism in the MSH3 mismatch repair gene is associated with the levels of somatic instability of the expanded CTG repeat in the blood DNA of myotonic dystrophy type 1 patients.
Morales Fernando, et al. DNA repair 2016 3 57-66 - Haplotype analysis and LD detection at DM1 locus.
Kumar Ashok, et al. Gene 2015 8 (1) 45-50 - Modelling and inference reveal nonlinear length-dependent suppression of somatic instability for small disease associated alleles in myotonic dystrophy type 1 and Huntington disease.
Higham Catherine F, et al. Journal of the Royal Society, Interface / the Royal Society 2013 11 (88) 20130605 - MBNL1 gene variants as modifiers of disease severity in myotonic dystrophy type 1.
Huin V, et al. Journal of neurology 2012 11 - Myotonic dystrophy type 1
From NCATS Genetic and Rare Diseases Information Center - Myotonic dystrophy type 2
From NCATS Genetic and Rare Diseases Information Center - Validation of sensitivity and specificity of tetraplet-primed PCR (TP-PCR) in the molecular diagnosis of myotonic dystrophy type 2 (DM2).
Catalli Claudio, et al. The Journal of molecular diagnostics : JMD 2010 9 (5) 601-6 - Haplotype analysis of the myotonic dystrophy type 1 (DM1) locus in the Korean population.
Kwon Min-Jung, et al. Annals of clinical and laboratory science 2010 0 (2) 156-62 - Myotonic dystrophy type 1 and PGD: ovarian stimulation response and correlation analysis between ovarian reserve and genotype.
Dechanet C, et al. Reproductive biomedicine online 2010 5 (5) 610-8 - Analysis of Single Nucleotide Polymorphisms (SNPs) of the small-conductance calcium activated potassium channel (SK3) gene as genetic modifier of the cardiac phenotype in myotonic dystrophy type 1 patients.
Rinaldi F, et al. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases 2008 12 82-9 - Molecular and clinical characteristics of myotonic dystrophy type 1 in koreans.
Kim So Yeon, et al. The Korean journal of laboratory medicine 2008 12 (6) 483-92 - Myotonic dystrophy type 2 found in two of sixty-three persons diagnosed as having fibromyalgia.
Auvinen Satu, et al. Arthritis and rheumatism 2008 11 (11) 3627-31 - High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany.
Suominen T, et al. Journal of neurology 2008 11 (11) 1731-6 - CTG expansion & haplotype analysis in DM1 gene in healthy Iranian population.
Shojasaffar Bahareh, et al. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2008 5 (2) 216-9 - Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions.
Arsenault M-E, et al. Neurology 2006 4 (8) 1248-50 - The correlation of CTG repeat length with material and social deprivation in myotonic dystrophy.
Laberge L, et al. Clinical genetics 2007 1 (1) 59-66 - [Myotonic dystrophy type 1 in cataract patients: molecular diagnosis for screening and genetic counseling].
Rojas María Verónica Muñoz, et al. Arquivos brasileiros de oftalmologia 0 0 (1) 15-20 - Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population.
Vallo L, et al. Molecular and cellular probes 2005 2 (1) 71-4 - No association of the SCA1 (CAG)31 allele with Huntington's disease, myotonic dystrophy type 1 and spinocerebellar ataxia type 3.
Hellenbroich Yorck, et al. Psychiatric genetics 2004 6 (2) 61-3 - Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1.
Hardin Bradley A, et al. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2003 7 (3) 227-32 - Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1.
Logigian EL, et al. Neurology 2004 4 (7) 1081-9
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: